Cerebrospinal Fluid (CSF) Analysis and Mass Spectrometry in the Alzheimer’s Disease Diagnostic Market
Refining mass spectrometry reference methods and automated cerebrospinal fluid (CSF) biomarker assays is maintaining diagnostic gold standards in the Alzheimer’s Disease Diagnostic Market. Multiplexed CSF assays quantify amyloid-beta, total tau, and neurofilament light chain (NfL) simultaneously from a single lumbar puncture sample, evaluating neurodegeneration severity and...
0 Comments 0 Shares 92 Views 0 Reviews